Publication | Open Access
YTHDC1 is downregulated by the YY1/HDAC2 complex and controls the sensitivity of ccRCC to sunitinib by targeting the ANXA1-MAPK pathway
67
Citations
32
References
2022
Year
We identified a novel YY1/HDAC2/YTHDC1/ANXA1 axis modulating the progression and chemosensitivity of ccRCC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1